Gene analysis (phospholipase c gamma 2) for common variants
Medicare pricing data for 35 providers across 5 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (phospholipase c gamma 2) for common variants (HCPCS code 81320) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $285.51, but hospitals typically charge $312.38 — a 1.1x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $285.51, your out-of-pocket cost would be approximately $57.10. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $285.51 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Florida | $286 | $312 | 24 | 14,764 | +0.0% |
| Louisiana | $286 | $352 | 1 | 17 | +0.0% |
| New Jersey | $286 | $296 | 3 | 30 | +0.0% |
| Pennsylvania | $286 | $291 | 2 | 30 | +0.0% |
| Texas | $269 | $302 | 5 | 16 | -5.8% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber